A one-time TMS and D-cycloserine treatment for PTSD in first responders
Treatments studied
Part of Mental health clinical trials.
This study tests a combination of a single magnetic brain stimulation session (TMS) and a medication called D-cycloserine (DCS), which may help strengthen positive memories and reduce post-traumatic stress disorder (PTSD) symptoms. It is designed for first responders who have been diagnosed with PTSD and are currently taking stable medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a first responder, whether currently active, on leave, or retired.
- You must be between 19 and 60 years old.
- You have a diagnosis of PTSD, confirmed by a specific assessment (score of 25 or more on the CAPS-5).
- Your depression symptoms are not too severe (score of 23 or less on the HAMD-17).
- Your medications (if any) have not changed in the past 4 weeks, and you are not planning to start or change therapy.
- You are able to attend scheduled treatment sessions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a type of brain stimulation called TMS combined with a medication called D-cycloserine to see if it helps reduce PTSD symptoms in military veterans. It may offer a new treatment option for those who haven't found relief from standard therapies.
This study tests transcranial magnetic stimulation (TMS) as a treatment for PTSD in Veterans. TMS uses magnetic pulses to stimulate brain areas linked to PTSD, aiming to reduce symptoms without medication.
This trial tests an accelerated form of transcranial magnetic stimulation (TMS) given daily for five days to treat PTSD. It may be an option for adults with moderate to severe PTSD who cannot get enough relief from standard treatments.
This study tests if personalized brain stimulation guided by your brain waves (EEG) can reduce PTSD symptoms. It's for veterans and first responders who have had PTSD for at least 6 months.
This trial tests a new form of brain stimulation (called targeted accelerated TMS) to see if it can help reduce symptoms of post-traumatic stress disorder (PTSD). It involves daily sessions over a short period and may be an option if you have at least moderate PTSD symptoms and a stable treatment plan.
This study tests a brain-stimulation treatment called TMS to see if it improves how people with PTSD unlearn fear and form safer memories. It may help reduce fear responses by targeting specific fear-circuit areas in the brain.
Hear when a new PTSD - Post Traumatic Stress Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.